Choroid is principally that portion of eye that lies in between the retina and the sclera. It is said that this particular region of eye comprises of blood vessels that constantly offers nutrients to the retinal part of our eye. Choroidal Neovascularization (CNV) Market size on the basis of methods of diagnosis spans Fluorescein Angiography (FA), Indocyanine Green (ICG) angiography, and spectral domain Optical Coherence Tomography (OCT).
Choroidal
Neovascularization (CNV) is an ailment, that is distinguished by the formation
of new blood vessels that evolve either because of the existence of Vascular
Endothelial Growth Factors or because of Age-related Macular Degeneration
(AMD). It has been noted that this particular disease is quite prominently
occurring in the population with flaws in the inmost stratum of the choroid
known as Bruch's membrane. It is linked with the production of new blood
vessels in the choroidal layer of eye.
These
blood vessels may suddenly break into the retina and give rise to disruption as
well as sight loss/vision loss. The key symptoms of this disorder may encompass
loss of vision, metamorphopsia, paracentral or central scotoma, and apparent
change in image size. This disease frequently takes place among the aged group
of population and among people who are suffering from severe myopia. Among all,
Fluorescein Angiography (FA) is the most frequently employed diagnosis
technique.
Request Sample Copy of This Market Research @
And
now days, it has been observed that the method of spectral domain OCT has
occupied the position of FA, the reason being its attached benefits and highly
accurate treatment provided by it. The studies show that CNV very often
originate from posterior pole lesions and therefore it becomes quite difficult
to spot and identify. Thus, it is very essential to take up an accurate and
precise diagnosis in order to get relief from CNV. Researchers have identified
a wide range of diagnosis methods of CNV along with various treatments.
As
far the treatments are concerned, the prominent ones include angiogenesis
inhibitors injection, photodynamic therapy, laser photocoagulation, low dose
radiation therapy as well as surgery. Among all these mentioned treatments, it is
said that angiogenesis inhibitor injection is the most traditional technique to
administer the development of blood vessels by decreasing the area of fluid
that is just below the retinal pigment epithelium.
The
prominent factor that is playing a major part in raising the Choroidal
Neovascularization (CNV) market share include high rate of increment in CNV
affected patients owing to augmented aged population. In addition, the
concerned government authorities and heath care departments across the globe are
taking up various initiatives for raising awareness among the masses regarding
the disease. Plus, they are offering appropriate diagnosis and treatments at
reasonable prices.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/choroidal-neovascularization-cnv-market
This
is in turn assisting in compelling the overall growth of Choroidal Neovascularization
(CNV) market. The only factors that are turning as major hurdles in the market
growth include high lack of awareness among masses especially in the African
and Asian regions regarding various kinds of eye diseases and soaring cost
attached with its treatment.
Additionally,
inaccessibility of better healthcare infrastructure, enhanced facilities and
high grade care of patients are still standing in the mid-way as major
challenges in the market growth. Choroidal Neovascularization (CNV) Market size
on the basis of geography spans North America, Europe, Asia-Pacific, South
America, and Middle East and Africa. As far as the geography is concerned, Asia
Pacific is currently leading the market and it is anticipated that it will rise
with a robust CAGR in the next couple of years particularly in the countries
like China, and India.
On
the other hand, North America is also emerging in the Choroidal
Neovascularization (CNV) market owing to the large number of aged population
present in the particular region. It is noted that the region is highly
affected by this disease. The key players operating in the Choroidal
Neovascularization (CNV) market include Bayer AG, Resolvyx Pharmaceuticals Inc,
F. Hoffmann-La Roche Ltd, Valeant Pharmaceuticals International Inc., and
Chengdu Kanghong Biotech Co. Ltd.
Comments
Post a Comment